Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:18:21.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, with a minimal header and footer. This indicates that access to the study details is blocked and the content is not available for review.
    Difference
    18%
    Check dated 2026-09-23T01:22:04.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision label updated to Revision: v3.7.0, replacing Revision: v3.6.6; this reflects a page version update without altering the study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:20:59.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a minor page update. No study details or user-facing content were altered.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was issued, replacing v3.6.4. This reflects a backend/page-system update with no new study details or visible content changes indicated.
    Difference
    0.1%
    Check dated 2026-08-11T17:07:53.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.4). The revision history now lists v3.6.4 as the current version, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-28T13:27:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.